 52 PM / Updated 11 minutes ago BRIEF-Arcturus Announces Expansion Of Collaboration With Takeda Reuters Staff 1 Min Read 
Jan 17 (Reuters) - Arcturus Therapeutics Ltd: 
* ARCTURUS THERAPEUTICS ANNOUNCES EXPANSION OF COLLABORATION WITH TAKEDA PHARMACEUTICALS TO DEVELOP RNA-BASED THERAPEUTICS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS (NASH) AND OTHER GI DISORDERS 
* ARCTURUS THERAPEUTICS - TAKEDA, CO TO DEVELOP RNA-BASED THERAPEUTICS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS, OTHER GASTROINTESTINAL 
* ARCTURUS - TO DEVELOP TREATMENT OF NASH AND GI RELATED DISORDERS USING COâ€˜S LUNAR LIPID-MEDIATED DELIVERY SYSTEMS & UNA OLIGOMER CHEMISTRY Source text for Eikon: Further company coverage: